ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sphere of biopharmaceuticals, offering promising improvements throughout many clinical and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA provides a safer, far more reputable substitute for therapeutic use, e